Anti-Biotherapeutic Antibody Detection
Multiple (Arthritis, Cancer, MS, Diabetes, etc.)
Pre-clinicalActive
Key Facts
Indication
Multiple (Arthritis, Cancer, MS, Diabetes, etc.)
Phase
Pre-clinical
Status
Active
Company
About ConquerAb
ConquerAb is addressing a critical unmet need in the multibillion-dollar biotherapeutics market: the lack of standardized, rapid diagnostics for detecting undesirable anti-drug antibodies (ADAs). The company's proprietary disposable devices enable point-of-care or at-home testing in under 15 minutes using a single drop of blood, facilitating immunogenicity comparisons and patient stratification. By standardizing ADA detection, ConquerAb seeks to generate integrable immunogenicity data to guide therapeutic selection, rational drug development, and vaccination monitoring, positioning itself at the intersection of diagnostics, big data, and AI-driven precision medicine.
View full company profile